Akso Health Group
AHG | NASDAQ
$1.29
+$0.08 (+6.61%)
At close: Nov 5, 2026, 4:00 PM ET
$1.31
+$0.02 (+1.55%)
After-hours:
Nov 5, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | 13.83M | 14.78M | 2.41M | 13.18M | 6M | 1.75M |
Cost of Revenue | 13.84M | 15.06M | 2.29M | 11.91M | 5.39M | 544.57K |
Gross Profit | -11.32K | -281.53K | 122.13K | 1.27M | 605.13K | 1.21M |
Operating Income | -4M | -166.3M | -8.64M | -14.27M | -3.26M | -27.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -20.7M | -166.27M | -9.09M | -13.07M | -4.01M | -3.81M |
Net Income | -18.67M | -134.98M | -9.46M | -1.36M | -16.85M | -34.83M |
Selling & General & Admin | 3.99M | 3.64M | 8.76M | 15.54M | 3.06M | 2.09M |
Research & Development | n/a | n/a | n/a | n/a | 421.19K | 441.41K |
Other Expenses | n/a | 162.38M | n/a | n/a | 382.95K | 25.83M |
Operating Expenses | 3.99M | 166.02M | 8.76M | 15.54M | 3.87M | 28.36M |
Interest Expense | n/a | n/a | n/a | n/a | 804.14K | 2.15M |
Selling & Marketing Expenses | n/a | n/a | 168.42K | 6.66K | 391.63K | 55.47K |
Cost & Expenses | 17.83M | 181.08M | 11.05M | 27.45M | 9.26M | 28.9M |
Income Tax Expense | -1.99M | -30.8M | 24.99K | 17.55K | 92.82K | 482.98K |
Shares Outstanding (Basic) | 722.71M | 285.1M | 20.81M | 7.62M | 6.62M | 5.43M |
Shares Outstanding (Diluted) | 722.71M | 285.1M | 23.83M | 7.62M | 6.62M | 5.43M |
EPS (Basic) | -0.03 | -0.48 | -0.45 | -0.06 | -2.55 | -0.26 |
EPS (Diluted) | -0.03 | -0.48 | -0.39 | -0.06 | -2.55 | -0.27 |
EBITDA | -1.63M | -1.77M | -8.64M | -14.25M | -3.19M | -28.9M |
EBIT | -4M | -3.92M | -8.64M | -14.27M | -3.2M | -28.91M |
Depreciation & Amortization | 2.37M | 2.15M | n/a | 18.39K | 18.39K | 15.16K |
Add to Watchlist
Select watchlists to add or remove AHG